Prudential Financial Inc Gilead Sciences, Inc. Transaction History
Prudential Financial Inc
- $70.8 Billion
- Q4 2024
A detailed history of Prudential Financial Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 981,253 shares of GILD stock, worth $107 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
981,253
Previous 1,026,723
4.43%
Holding current value
$107 Million
Previous $86.1 Million
5.32%
% of portfolio
0.13%
Previous 0.12%
Shares
40 transactions
Others Institutions Holding GILD
# of Institutions
2,101Shares Held
987MCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.6 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.84 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.6 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.33 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $137B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...